What is the treatment for poison ivy exposure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Poison Ivy Exposure

For poison ivy dermatitis, immediately wash the exposed area with soap and water, apply high-potency topical corticosteroids (such as mometasone furoate 0.1% or betamethasone valerate 0.1% ointment) twice daily for mild-to-moderate cases, and initiate systemic prednisone 0.5-1 mg/kg daily with a 4-6 week taper for severe cases. 1

Immediate Decontamination (Time-Critical)

The effectiveness of decontamination drops precipitously with time, making immediate action essential:

  • Wash with soap and water immediately after contact to remove 100% of urushiol oils, but effectiveness plummets to 50% at 10 minutes, 25% at 15 minutes, and only 10% at 30 minutes. 1, 2
  • Remove all contaminated clothing, jewelry, and materials before washing, and brush off any dry plant material first. 1, 2
  • If immediate washing is not possible, commercial decontamination products, hand cleaners, or dishwashing soap can still produce 55-70% symptom reduction even when used up to 2 hours after exposure. 1, 2

Treatment Algorithm by Severity

Mild-to-Moderate Dermatitis

  • Apply moderate-to-high potency topical corticosteroids (mometasone furoate 0.1% ointment or betamethasone valerate 0.1% ointment) twice daily to affected areas. 1
  • Over-the-counter hydrocortisone is FDA-approved for poison ivy but has NOT been shown to improve symptoms in randomized trials and should not be relied upon. 1, 3
  • Add oral antihistamines: non-sedating second-generation antihistamines (loratadine 10 mg daily) during daytime, or first-generation antihistamines (diphenhydramine 25-50 mg or hydroxyzine 25-50 mg) at bedtime for sedation. 1
  • Note that antihistamines may primarily help with sleep rather than directly relieving local itching. 1, 2

Severe Cases (Widespread Involvement, Facial/Genital Involvement)

  • Initiate systemic corticosteroids immediately with prednisone 0.5-1 mg/kg body weight for 7 days, followed by a weaning dose over 4-6 weeks. 1
  • Continue high-potency topical corticosteroids to affected areas concurrently. 1
  • Add oral antihistamines for symptomatic relief. 1
  • Critical pitfall: Ensure the corticosteroid taper is long enough (4-6 weeks minimum) to prevent rebound flare, which is common with shorter courses. 1

Supportive Care Measures

  • Apply cool compresses to affected areas for symptomatic relief. 1, 2
  • Consider oatmeal baths for widespread symptoms, though evidence supporting this is limited. 1, 2
  • Use alcohol-free moisturizing creams or ointments twice daily, preferably with urea-containing (5-10%) moisturizers. 1
  • Avoid frequent washing with hot water and skin irritants, including over-the-counter anti-acne medications, solvents, or disinfectants. 1
  • Apply sunscreen SPF 15 to exposed areas every 2 hours when outside. 1

Critical Warning Signs Requiring Antibiotics

Monitor for secondary bacterial infection, which requires antibiotic therapy:

  • Increased warmth and tenderness at the site 1
  • Purulent drainage 1
  • Honey-colored crusting 1
  • Cellulitis (spreading erythema, warmth, swelling) 1

Expected Course

  • Symptoms typically begin within days of exposure and last up to 3 weeks without treatment. 1
  • Approximately 50-75% of individuals react to urushiol, the allergic compound in poison ivy. 1, 4

References

Guideline

Poison Ivy Treatment and Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment for Poison Oak Exposure

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Poison Ivy, Oak, and Sumac Dermatitis: What Is Known and What Is New?

Dermatitis : contact, atopic, occupational, drug, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.